TorsinA Antibodies

Santa Cruz Biotechnology offers a broad range of TorsinA monoclonal antibodies for investigating TorsinA's role in cellular processes. TorsinA monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TorsinA is a member of the torsin family, playing essential roles in regulating cellular stress responses and maintaining nuclear envelope integrity. Mutations in TorsinA are linked to DYT1 dystonia, a movement disorder characterized by involuntary muscle contractions. Research focusing on TorsinA function continues to reveal insights into molecular mechanisms underlying DYT1 dystonia. Understanding TorsinA's cellular functions may lead to breakthrough therapeutic approaches for movement disorders. Investigating TorsinA's role in nuclear envelope maintenance provides valuable insights into cellular organization and disease mechanisms. Current research explores how TorsinA influences cellular stress responses and their impact on neurological function. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TorsinA's role in health and disease.